Skip to main content
. 2010 Mar 29;5:15–23. doi: 10.4137/aci.s4431

Table S1.

Matrix effects from different sources of plasma (EDTA as the antocoagulant). Plasma samples spiked with lumefantrine at 900 ng/mL.

Plasma (lot #) Replicate Anticoagulant Conc. (LF) ng/mL Theoretical conc (units) ng/mL Mean ng/mL SD % CV % Dev
1 (23-08172) 1 EDTA 855 900 845 22.1 2.6% −6.1
2 EDTA 861 900
3 EDTA 820 900
2 (23-08176) 1 EDTA 853 900 895 37.6 4.2% −0.5
2 EDTA 908 900
3 EDTA 925 900
3 (23-08180) 1 EDTA 864 900 903 34.1 3.8% 0.3
2 EDTA 918 900
3 EDTA 927 900
4 (55-20429) 1 EDTA 950 900 947 17.2 1.8% 5.2
2 EDTA 962 900
3 EDTA 928 900
5 (23-06316) 1 EDTA 920 900 929 8.1 0.9% 3.2
2 EDTA 930 900
3 EDTA 936 900
6 (22-97035) 1 EDTA 899 900 939 36.5 3.9% 4.4
2 EDTA 949 900
3 EDTA 970 900